NervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates

Expanded CONNECT SCI Study data demonstrated unprecedented durable improvement in function, independence, and quality of life in individuals living with chronic spinal cord injury Completed a U.S. Food and Drug Administration (FDA) Type C meeting in September; FDA confirmed that multiple regulatory routes are available to support approval of NVG-291 as the first pharmacologic treatment […]

Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

(NasdaqGM:CLSD), – Intended to Maximize Stakeholder Value Through Structured Process – – Validated SCS Microinjector(R) Delivery Platform Anchored by Commercial Product and Five Suprachoroidal Licensing Collaborations with Future Royalty Revenue Potential – – CLS-AX TKI Program Includes Phase 3-Ready Asset in Wet AMD and Path for Phase 2b/3 Trial in Diabetic Retinopathy – – IND-Ready

Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process GlobeNewswire November 24, 2025 – Intended to Maximize Stakeholder Value Through Structured Process – – Validated SCS Microinjector(R) Delivery Platform Anchored by Commercial Product and Five Suprachoroidal Licensing Collaborations with Future Royalty Revenue Potential – – CLS-AX TKI Program Includes Phase

Silver47 Drills 606 g/t Silver Equivalent* over 9.65 m at the Silver-Rich Red Mountain Project, Alaska

Vancouver, British Columbia–(Newsfile Corp. – November 24, 2025) – Silver47 Exploration Corp. (TSXV: AGA) (OTCQB: AAGAF) (“Silver47” or the “Company”) is pleased to report all remaining assay results from the recently completed drill program at the Company’s wholly-owned and flagship Red Mountain Project in Alaska, USA. Key Highlights: Bonanza intercept at Dry Creek: 606 g/t silver equivalent*

FCX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Freeport-McMoRan Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Freeport-McMoRan Inc. ("Freeport" or "the Company") (NYSE:FCX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Veeva Announces Expanded Partnership with Roche

Veeva to deliver next generation customer engagement with agentic AI for Roche Veeva Systems (NYSE: VEEV) today announced that Roche Pharmaceuticals has chosen to extend its partnership with Veeva Systems by adopting Veeva Vault CRM. https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo_v2.jpg “Roche and Veeva have partnered for many years,” said Veeva CEO Peter Gassner. “We are honored to extend our

iHuman to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference

Beijing, China–(Newsfile Corp. – November 24, 2025) – iHuman Inc. (NYSE: IH), a leading provider of tech-powered, intellectual development products in China, today announced that its Investor Relations Director, Justin Zhang, will present at NobleCon21 – Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton,

Cheelcare Receives “Compliant” Rating from Health Canada Following Routine Inspection

Markham, Ontario–(Newsfile Corp. – November 24, 2025) – Cheelcare Inc. (TSXV: CHER) (“Cheelcare” or the “Company”), a Canadian leader in assistive mobility devices, has received a “Compliant” rating from Health Canada, following a routine regulatory inspection conducted between October 22 and November 3, 2025. The inspection was conducted at Cheelcare’s new 16,000 sq. ft. manufacturing

QIMC's First-Mover Advantage in Nova Scotia Accelerates Regional Claim Rush as Company Prepares for Winter Drilling in Advocate

Montreal, Quebec–(Newsfile Corp. – November 24, 2025) – Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ) (“QIMC” or the “Company”), a leader in natural hydrogen development, today announced that its pioneering exploration model has ignited a major staking rush in Nova Scotia, confirming the province as Canada’s most promising natural hydrogen jurisdiction –

Plurilock Announces Dates for Third Quarter 2025 Financial Results

Plurilock will announce Q3 2025 financial results aftermarket Wednesday November 26, 2025 Management will host a conference call on Thursday November 27, 2025, at 11am ET Vancouver, British Columbia–(Newsfile Corp. – November 24, 2025) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) (“Plurilock” or the “Company”), a global cybersecurity systems integrator, announces that it plans

Scroll to Top